Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer

Clinical trial NCT00024427 · COMPLETED

Trial details

NCT number: NCT00024427
Sponsor: Wellstat Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Drug/Agent Toxicity by Tissue/Organ Pancreatic Cancer

Start date: 2001-02-01
Primary completion: 2006-02-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.